Laboratory Corp. Of America Holdings (NYSE: LH) Could Achieve Gains In The Near Future

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted Labcorp to Announce Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

Laboratory Corp. Of America Holdings is listed on the NYSE in the Healthcare sector while operating in the Diagnostics & Research industry. At the end of the last regular session, the stock closed at $223.00 and fluctuated between $225.38 as its day high and $220.63 as its day low. The current market capitalization of Laboratory Corp. Of America Holdings is $18.93B. A total of 0.66 million shares were traded on the day, compared to an average of 791.69K shares.

Insider Activity

Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, LH has seen 0 BUY and 1 SELL insider trades, representing the acquisition of 0 and the disposition of 1,384 shares. Over the last 12 months, there were 55 BUYs and 55 SELLs from insiders. Insiders purchased 127,436 shares during that period but sold 71,250.

In the most recent transaction, Wilkinson Peter J sold 1,384 shares of LH for 210.71 per share on Nov 16. After the transaction, the SVP, Chief Accounting Officer now owns 2,087 company shares. In a previous transaction on Aug 08, ANDERSON KERRII B sold 5,000 shares at 211.57 per share. LH shares that Director owns now total 15,275.

Among the insiders who sold shares, van der Vaart Sandra D disposed of 212 shares on Jun 29 at a per-share price of $240.00. This resulted in the EVP, Chief Legal Officer holding 7,605 shares of LH after the transaction. In another insider transaction, Kirchgraber Paul R sold 4,300 shares at $216.91 per share on May 19. Company shares held by the CEO, Covance Drug Development now total 12,946.

Dividend

The reasons why investors prefer dividend-paying companies are that dividends generate immediate cash flow and indicate that the company will perform well in the future. Laboratory Corp. Of America Holdings pays an annual dividend of $1.82, resulting in a dividend yield of 0.82%, and it has a price to earnings (P/E) ratio of 29.83. LH’s most recent ex-dividend date was 2/26/2024 when it declared a $0.72 quarterly dividend that was paid in cash on 3/13/2024. Previously, the company paid the dividend on 12/12/2023 with an ex-dividend date of 11/7/2023. The LH stock dividend was $0.72 per share in cash.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for LH in the last 3 months, the mean price target is $241.31 with high estimates of $270.00 and low estimates of $215.00. In terms of 52-week highs and lows, LH has a high of $234.09 and a low of $179.58.

As of this writing, LH has an earnings estimate of $3.28 per share for the current quarter. EPS was calculated based on a consensus of 13 estimates, with a high estimate of $3.4 per share and a lower estimate of $3.11. The company reported an EPS of $3.42 in the last quarter, which was -3.10% lower than expectations of $3.53.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. LH’s latest balance sheet shows that the firm has $1.47B in Cash & Short Term Investments as of fiscal 2021. There were $6.34B in debt and $2.78B in liabilities at the time. Its Book Value Per Share was $92.73, while its Total Shareholder’s Equity was $10.27B.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for LH is Buy with a score of 4.36.

Most Popular

Related Posts